Drug profile · INN
aminosalicylic acid resin complex
REZIPAS
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
aminosalicylic acid resin complex (REZIPAS) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN aminosalicylic acid resin complex
Brand REZIPAS
Route ORAL
Formulation POWDER
Related patents
Search patents →Frequently asked questions
What is aminosalicylic acid resin complex?
aminosalicylic acid resin complex (REZIPAS) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aminosalicylic acid resin complex?
REZIPAS is a marketed brand name for aminosalicylic acid resin complex. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aminosalicylic acid resin complex?
aminosalicylic acid resin complex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.